Introduction
Vespilo is a prescription medication that contains the active ingredient Desloratadine. It is available under the brand name Vespilo. Desloratadine is an antihistamine that is commonly used to relieve symptoms associated with allergies, such as sneezing, runny nose, itching, and watery eyes.
Uses
Vespilo is primarily prescribed to treat the symptoms of seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis. These conditions are characterized by inflammation of the nasal passages caused by an allergic reaction. Vespilo can help alleviate the uncomfortable symptoms associated with these conditions, allowing patients to experience relief from sneezing, nasal congestion, and itching.
Dosage and Administration
The recommended dosage of Vespilo for adults and children above 12 years of age is one tablet (5 mg) once daily. Follow the instructions provided by your healthcare provider or the medication label. Vespilo can be taken with or without food, but it is preferable to take it with water.
Mechanism of Action
Vespilo works by blocking the action of histamine, a substance in the body that is responsible for triggering allergic reactions. By inhibiting histamine, Desloratadine helps to reduce the symptoms of allergies, such as itching, sneezing, and runny nose.
Side Effects
Common side effects may include headache, dry mouth, fatigue, and nausea. These side effects are generally mild and temporary.
In rare cases, Vespilo may cause more serious side effects such as allergic reactions, difficulty breathing, or swelling of the face, lips, tongue, or throat. If you experience any of these symptoms, seek immediate medical attention.
Drug Interactions
Vespilo may interact with certain medications, potentially affecting their effectiveness or increasing the risk of side effects. Inform your healthcare provider about all the medications, including prescription, over-the-counter, and herbal supplements, that you are currently taking.
Some medications that may interact with Vespilo include ketoconazole, erythromycin, and fluoxetine. These interactions can increase the concentration of Desloratadine in the body, leading to an increased risk of side effects. Always consult your healthcare provider before starting or stopping any medications while taking Vespilo.
Precautions
Before taking Vespilo, inform your healthcare provider if you have any known allergies, medical conditions, or if you are pregnant or breastfeeding. Vespilo should be used with caution in patients with liver or kidney problems.
Vespilo may cause drowsiness in some individuals. Avoid activities that require mental alertness, such as driving or operating machinery, until you know how the medication affects you.
Storage
Patient Tips
- Take Vespilo as directed by your healthcare provider or as instructed on the medication label.
- If you forget to take a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
- Avoid consuming alcohol while taking Vespilo, as it may enhance the sedative effects of the medication.
- If you experience any unusual or bothersome side effects while taking Vespilo, contact your healthcare provider for further guidance.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Desloratadine 5 mg film-coated tablets (Health Professionals SmPC) Available at:
- Desloratadine (Drugs.com) [Accessed 7 Jun. 2024] (online) Available at:
- desloratadine (RX) [Accessed 14 Jun. 2024] (online) Available at:
- Desloratadine (MedlinePlus) [Accessed 24 Jun. 2024] (online) Available at:
- Devillier P, Roche N, Faisy C. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review. Clin Pharmacokinet. 2008;47(4):217-30. doi: 10.2165/00003088-200847040-00001. [Accessed 30 Jun. 2024] Available at:
Reviews
There are no reviews yet.